28 April 2021 - Being transparent about the results of completed clinical trials enables important advances in the development of medical ...
22 April 2021 - Rapid publication following approval. ...
2 March 2021 - Openness and transparency are key to building confidence in COVID-19 vaccines. Today, EMA and Health Canada ...
22 February 2021 - The EMA has published a draft agenda for this week's CHMP meeting. ...
2 February 2021 - The European Medicines Agency has released a draft guidance to assist drug developers using its Priority ...
25 January 2021 - The EMA has published a draft agenda for this week's CHMP meeting. ...
17 December 2020 - Today, the U.S. FDA published an update to the “List of Off-Patent, Off-Exclusivity Drugs without an Approved ...
7 December 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...
12 November 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...
12 October 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...
7 October 2020 - The FDA has laid out its safety standards for developers of COVID-19 vaccines after the White House ...
2 October 2020 - The BIO trade group, whose members include most of the vaccine makers, asked the health secretary to ...
16 September 2020 - The European Medicines Agency is on the verge of releasing revised guidance for advanced therapy medicinal ...
14 September 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...
24 August 2020 - The US FDA has said it will penalise sponsors of clinical trials that do not report ...